OrbiMed Advisors LLC's Form 4 filing
NeuroPace Inc (NPCE) · filed Apr 15, 2024
- Accession no.
- 0000947871-24-000395
- Filed
- Apr 15, 2024, 5:25 PM ET
- Trade date
- Apr 11-12, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $7.03M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | 10% Owner |
| OrbiMed Capital GP VI LLCCIK 0001682115 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 11, 2024 | Common Stock | SSaleDisposed | −461,899 | $14.49F1 | −$6,692,916.51 | 3,542,068 | Indirect | |
| Apr 12, 2024 | Common Stock | SSaleDisposed | −23,101 | $14.42 | −$333,116.42 | 3,518,967 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents the weighted average sale price of the Issuer's common stock ("Shares") sold, ranging from a low of $14.47 to a high of$14.66 per Share. The Reporting Persons undertake, upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of Shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.